Skip to main content

Animations

MJFF Publications

1881 - 1890 of 9200 Results
Title
Year
  • Year
  • 2025
  • 2018
  • 2017
  • 2019
  • 2023
  • 2022
  • 2015
  • 2021
  • 2014
  • 2019
  • Summary Details
    OPEN
    Title: PubMedMetaTool: Automated metadata extraction from PubMed using Python for bibliometric analysis
    Journal Name: Software Impacts
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.simpa.2025.100766
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Multiple system atrophy and apolipoprotein E
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27297
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12583
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Sacral nerve stimulation improves gait in Parkinson's disease
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2019.03.074
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105954
    Citation Count: 3
  • Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset
    2022
    Summary Details
    RESTRICTED
    Title: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal Tinnitus
    Journal Name: BioMed Research International
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2015/569052
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00536
    Citation Count: 24
  • Summary Details
    OPEN
    Title: A cell culture model for monitoring α-synuclein cell-to-cell transfer
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.07.003
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic Stimulation
    Journal Name: Research
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1155/2019/7109535
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.